Selected research
Industry Research
Bordetella Vaccine for Dogs Industry Research Report 2026
Market perspective
The global Bordetella Vaccine for Dogs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Bordetella Vaccine for Dogs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Bordetella Vaccine for Dogs is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Bordetella Vaccine for Dogs is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Bordetella Vaccine for Dogs include Elanco, Boehringer Ingelheim(Merial), Merck Animal Health and Zoetis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Bordetella Vaccine for Dogs market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Bordetella Vaccine for Dogs Market by Company
Elanco
Boehringer Ingelheim(Merial)
Merck Animal Health
Zoetis
Bordetella Vaccine for Dogs Segment by Type
Injectable Bordetella Vaccine
Oral Bordetella Vaccine
Intranasal Bordetella Vaccine
Bordetella Vaccine for Dogs Segment by Application
Puppies
Adult Dogs
Bordetella Vaccine for Dogs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bordetella Vaccine for Dogs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Bordetella Vaccine for Dogs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bordetella Vaccine for Dogs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Bordetella Vaccine for Dogs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Bordetella Vaccine for Dogs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Bordetella Vaccine for Dogs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Injectable Bordetella Vaccine
- Oral Bordetella Vaccine
- Intranasal Bordetella Vaccine
Applications
- Puppies
- Adult Dogs
Companies covered
- Elanco
- Boehringer Ingelheim(Merial)
- Merck Animal Health
- Zoetis
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Bordetella Vaccine for Dogs Market Size (2021-2032)
- 2.2.2 Global Bordetella Vaccine for Dogs Sales (2021-2032)
- 2.2.3 Global Bordetella Vaccine for Dogs Market Average Price (2021-2032)
- 2.3 Bordetella Vaccine for Dogs by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Injectable Bordetella Vaccine
- 2.3.3 Oral Bordetella Vaccine
- 2.3.4 Intranasal Bordetella Vaccine
- 2.4 Bordetella Vaccine for Dogs by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Puppies
- 2.4.3 Adult Dogs
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Bordetella Vaccine for Dogs Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Bordetella Vaccine for Dogs Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Bordetella Vaccine for Dogs Revenue of Manufacturers (2021-2026)
- 3.4 Global Bordetella Vaccine for Dogs Average Price by Manufacturers (2021-2026)
- 3.5 Global Bordetella Vaccine for Dogs Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Bordetella Vaccine for Dogs, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Bordetella Vaccine for Dogs, Product Type & Application
- 3.8 Global Manufacturers of Bordetella Vaccine for Dogs, Established Date
- 3.9 Global Bordetella Vaccine for Dogs Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Elanco
- 4.1.1 Elanco Company Information
- 4.1.2 Elanco Business Overview
- 4.1.3 Elanco Bordetella Vaccine for Dogs Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Elanco Bordetella Vaccine for Dogs Product Portfolio
- 4.1.5 Elanco Recent Developments
- 4.2 Boehringer Ingelheim(Merial)
- 4.2.1 Boehringer Ingelheim(Merial) Company Information
- 4.2.2 Boehringer Ingelheim(Merial) Business Overview
- 4.2.3 Boehringer Ingelheim(Merial) Bordetella Vaccine for Dogs Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Boehringer Ingelheim(Merial) Bordetella Vaccine for Dogs Product Portfolio
- 4.2.5 Boehringer Ingelheim(Merial) Recent Developments
- 4.3 Merck Animal Health
- 4.3.1 Merck Animal Health Company Information
- 4.3.2 Merck Animal Health Business Overview
- 4.3.3 Merck Animal Health Bordetella Vaccine for Dogs Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Merck Animal Health Bordetella Vaccine for Dogs Product Portfolio
- 4.3.5 Merck Animal Health Recent Developments
- 4.4 Zoetis
- 4.4.1 Zoetis Company Information
- 4.4.2 Zoetis Business Overview
- 4.4.3 Zoetis Bordetella Vaccine for Dogs Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Zoetis Bordetella Vaccine for Dogs Product Portfolio
- 4.4.5 Zoetis Recent Developments
5 Global Bordetella Vaccine for Dogs Market Scenario by Region
- 5.1 Global Bordetella Vaccine for Dogs Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Bordetella Vaccine for Dogs Sales by Region: 2021-2032
- 5.2.1 Global Bordetella Vaccine for Dogs Sales by Region: 2021-2026
- 5.2.2 Global Bordetella Vaccine for Dogs Sales by Region: 2027-2032
- 5.3 Global Bordetella Vaccine for Dogs Revenue by Region: 2021-2032
- 5.3.1 Global Bordetella Vaccine for Dogs Revenue by Region: 2021-2026
- 5.3.2 Global Bordetella Vaccine for Dogs Revenue by Region: 2027-2032
- 5.4 North America Bordetella Vaccine for Dogs Market Facts & Figures by Country
- 5.4.1 North America Bordetella Vaccine for Dogs Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Bordetella Vaccine for Dogs Sales by Country (2021-2032)
- 5.4.3 North America Bordetella Vaccine for Dogs Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Bordetella Vaccine for Dogs Market Facts & Figures by Country
- 5.5.1 Europe Bordetella Vaccine for Dogs Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Bordetella Vaccine for Dogs Sales by Country (2021-2032)
- 5.5.3 Europe Bordetella Vaccine for Dogs Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Bordetella Vaccine for Dogs Market Facts & Figures by Country
- 5.6.1 Asia Pacific Bordetella Vaccine for Dogs Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Bordetella Vaccine for Dogs Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Bordetella Vaccine for Dogs Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Bordetella Vaccine for Dogs Market Facts & Figures by Country
- 5.7.1 South America Bordetella Vaccine for Dogs Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Bordetella Vaccine for Dogs Sales by Country (2021-2032)
- 5.7.3 South America Bordetella Vaccine for Dogs Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Bordetella Vaccine for Dogs Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Bordetella Vaccine for Dogs Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Bordetella Vaccine for Dogs Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Bordetella Vaccine for Dogs Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Bordetella Vaccine for Dogs Sales by Type (2021-2032)
- 6.1.1 Global Bordetella Vaccine for Dogs Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Bordetella Vaccine for Dogs Sales Market Share by Type (2021-2032)
- 6.2 Global Bordetella Vaccine for Dogs Revenue by Type (2021-2032)
- 6.2.1 Global Bordetella Vaccine for Dogs Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Bordetella Vaccine for Dogs Revenue Market Share by Type (2021-2032)
- 6.3 Global Bordetella Vaccine for Dogs Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Bordetella Vaccine for Dogs Sales by Application (2021-2032)
- 7.1.1 Global Bordetella Vaccine for Dogs Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Bordetella Vaccine for Dogs Sales Market Share by Application (2021-2032)
- 7.2 Global Bordetella Vaccine for Dogs Revenue by Application (2021-2032)
- 7.2.1 Global Bordetella Vaccine for Dogs Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Bordetella Vaccine for Dogs Revenue Market Share by Application (2021-2032)
- 7.3 Global Bordetella Vaccine for Dogs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Bordetella Vaccine for Dogs Value Chain Analysis
- 8.1.1 Bordetella Vaccine for Dogs Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Bordetella Vaccine for Dogs Production Mode & Process
- 8.2 Bordetella Vaccine for Dogs Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Bordetella Vaccine for Dogs Distributors
- 8.2.3 Bordetella Vaccine for Dogs Customers
9 Global Bordetella Vaccine for Dogs Analyzing Market Dynamics
- 9.1 Bordetella Vaccine for Dogs Industry Trends
- 9.2 Bordetella Vaccine for Dogs Industry Drivers
- 9.3 Bordetella Vaccine for Dogs Industry Opportunities and Challenges
- 9.4 Bordetella Vaccine for Dogs Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst